A phase II study of S-1 and oxaliplatin as first-line therapy for patients with recurrent or metastatic gastric cancer

被引：0
|
作者：
Kim, H.
Lee, G.
Kim, H.
Lee, O.
Hwang, I.
Kang, J.
机构：
[1] Gyeongsang Natl Univ, Sch Med, Jinju, South Korea
[2] Kangwon Natl Univ, Sch Med, Chunchon, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.15583
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
15583
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A PHASE II STUDY OF S-1 AND OXALIPLATIN AS FIRST-LINE THERAPY FOR PATIENTS WITH RECURRENT OR METASTATIC GASTRIC CANCER
    Kim, H. G.
    Kang, M.
    Kim, S.
    Lee, S. I.
    Lee, G.
    Kang, J. H.
    ANNALS OF ONCOLOGY, 2008, 19 : 182 - 182
  • [2] Phase I/II study of oxaliplatin with oral S-1 as first-line therapy for patients with metastatic colorectal cancer
    Yamada, Y.
    Tahara, M.
    Miya, T.
    Satoh, T.
    Shirao, K.
    Shimada, Y.
    Ohtsu, A.
    Sasaki, Y.
    Tanigawara, Y.
    BRITISH JOURNAL OF CANCER, 2008, 98 (06) : 1034 - 1038
  • [3] Phase I/II study of oxaliplatin with oral S-1 as first-line therapy for patients with metastatic colorectal cancer
    Y Yamada
    M Tahara
    T Miya
    T Satoh
    K Shirao
    Y Shimada
    A Ohtsu
    Y Sasaki
    Y Tanigawara
    British Journal of Cancer, 2008, 98 : 1034 - 1038
  • [4] A phase II study of S-1 and oxaliplatin (SOx) combination chemotherapy as a first-line therapy for patients with advanced gastric cancer
    Sung Yong Oh
    Hyuk-Chan Kwon
    Sang-Ho Jeong
    Young-Tae Joo
    Young-Joon Lee
    Su hee Cho
    Myoung Hee Kang
    Se-il Go
    Gyeong-won Lee
    Hoon gu Kim
    Jung Hun Kang
    Investigational New Drugs, 2012, 30 : 350 - 356
  • [5] Phase II study of oxaliplatin combined with S-1 (SOX) as first-line therapy for patients with advanced gastric cancer (AGC)
    Takiuchi, H.
    Koizumi, W.
    Yamada, Y.
    Boku, N.
    Komatsu, Y.
    Fuse, N.
    Muro, K.
    Tsuburaya, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [6] A phase II study of S-1 and oxaliplatin (SOx) combination chemotherapy as a first-line therapy for patients with advanced gastric cancer
    Oh, Sung Yong
    Kwon, Hyuk-Chan
    Jeong, Sang-Ho
    Joo, Young-Tae
    Lee, Young-Joon
    Cho, Su Hee
    Kang, Myoung Hee
    Go, Se-il
    Lee, Gyeong-won
    Kim, Hoon Gu
    Kang, Jung Hun
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (01) : 350 - 356
  • [7] Multicenter Phase II Study of Oxaliplatin, Irinotecan, and S-1 as First-Line Treatment for Patients with Recurrent or Metastatic Biliary Tract Cancer
    Yoo, Changhoon
    Han, Boram
    Kim, Hyeong Su
    Kim, Kyu-pyo
    Kim, Deokhoon
    Jeong, Jae Ho
    Lee, Jae-Lyun
    Kim, Tae Won
    Kim, Jung Han
    Choi, Dae Ro
    Ha, Hong Il
    Seo, Jinwon
    Chang, Heung-Moon
    Ryoo, Baek-Yeol
    Zang, Dae Young
    CANCER RESEARCH AND TREATMENT, 2018, 50 (04): : 1324 - 1330
  • [8] Phase II study of docetaxel, oxaliplatin, and S-1 therapy in patients with metastatic gastric cancer
    Hyeong Su Kim
    Min-Hee Ryu
    Dae Young Zang
    Baek-Yeol Ryoo
    Dae Hyun Yang
    Ji Woong Cho
    Man Sup Lim
    Min-Jeong Kim
    Boram Han
    Dae Ro Choi
    Jung Han Kim
    Joo Young Jung
    Hunho Song
    Choong Kee Park
    Yoon-Koo Kang
    Gastric Cancer, 2016, 19 : 579 - 585
  • [9] Phase II study of docetaxel, oxaliplatin, and S-1 therapy in patients with metastatic gastric cancer
    Kim, Hyeong Su
    Ryu, Min-Hee
    Zang, Dae Young
    Ryoo, Baek-Yeol
    Yang, Dae Hyun
    Cho, Ji Woong
    Lim, Man Sup
    Kim, Min-Jeong
    Han, Boram
    Choi, Dae Ro
    Kim, Jung Han
    Jung, Joo Young
    Song, Hunho
    Park, Choong Kee
    Kang, Yoon-Koo
    GASTRIC CANCER, 2016, 19 (02) : 579 - 585
  • [10] A phase II study of biweekly oxaliplatin and S-1(SOX) as first-line combination therapy in patients with advanced gastric cancer.
    Deng, Jing
    Shi, Genming
    Zheng, Yulong
    Qian, Jiong
    Jiang, Haiping
    Mao, Chenyu
    Zhang, Xiaochen
    Wang, Yao
    Xu, Nong
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345